Oxidative stress in hepatitis C infected end-stage renal disease subjects

BMC Infectious Diseases

Volumn 6, Issue , 2006, Pages

  Horoz, Mehmet ^a   Bolukbas, Cengiz ^a   Bolukbas, Filiz F ^a   Aslan, Mehmet ^a   Koylu, Ahmet O ^a   Selek, Sahbettin ^a   Erel, Ozcan ^a  

^a HARRAN UNIVERSITY   (Turkey)

Author keywords

[No Author keywords available]

Indexed keywords

ALANINE AMINOTRANSFERASE; ANTIOXIDANT; CREATININE; PEROXIDE; URIC ACID; VIRUS RNA;

ADULT; ALANINE AMINOTRANSFERASE BLOOD LEVEL; ANTIOXIDANT ACTIVITY; ARTICLE; BLOOD SAMPLING; CLINICAL ARTICLE; COMORBIDITY; CONTROLLED STUDY; CREATININE BLOOD LEVEL; FEMALE; HEMODIALYSIS; HEPATITIS C; HEPATITIS C VIRUS; HUMAN; KIDNEY FAILURE; LINEAR REGRESSION ANALYSIS; MALE; OXIDATIVE STRESS; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RNA ANALYSIS; UREA NITROGEN BLOOD LEVEL; URIC ACID BLOOD LEVEL;

ADULT; ANTIOXIDANTS; CASE-CONTROL STUDIES; FEMALE; HEPATITIS C; HUMANS; KIDNEY FAILURE, CHRONIC; MALE; MIDDLE AGED; OXIDATIVE STRESS; PEROXIDES; RENAL DIALYSIS;

EID: 33747296206     PISSN: 14712334     EISSN: 14712334     Source Type: Journal    
DOI: 10.1186/1471-2334-6-114     Document Type: Article

References (38)

1. Halliwell B, Gutteridge JMC: Free Radicals in Biology and Medicine. 3rd edition. London: Oxford Science Publications; 1999.
2. Baliga R, Ueda N, Walker PD, Shah SV: Oxidant mechanisms in toxic acute renal failure. Drug Metab Rev 1999, 31:971-997.
3. Descamps-Latscha B, Witko-Sarsat V: Importance of oxidatively modified proteins in chronic renal failure. Kidney Int Suppl 2001, 78:108-113.
4. Himmelfarb J, McMonagle E, McMenamin E: Plasma protein thiol oxidation and carbonyl formation in chronic renal failure. Kidney Int 2000, 58:2571-2578.
5. Miyata T, Fu MX, Kurokawa K, van Ypersele de Strihou C, Thorpe SR, Baynes JW: Autoxidation products of both carbohydrates and lipids are increased in uremic plasma: is there oxidative stress in uremia? Kidney Int 1998, 54:1290-1295.
6. Zoccali C, Mallamaci F, Tripepi G: AGEs and carbonyl stress: potential pathogenetic factors of long-term uraemic complications. Nephrol Dial Transplant 2000, 15:7-11.
7. Miyata T, Sugiyama S, Saito A, Kurokawa K: Reactive carbonyl compounds related uremic toxicity ("carbonyl stress"). Kidney Int 2001, 59:25-31.
8. Ichikawa I, Kiyama S, Yoshioka T: Renal antioxidant enzymes: their regulation and function. Kidney Int 1994, 45:1-9.
9. Witko-Sarsat V, Friedlander M, Capeillere-Blandin C, Nguyen-Khoa T, Nguyen AT, Zingraff J, Jungers P, Descamps-Latscha B: Advanced oxidation protein products as a novel marker of oxidative stress in uremia. Kidney Int 1996, 49:1304-1313.
10. Toborek M, Wasik T, Drozdz M, Klin M, Magner-Wrobel K, Kopieczna-Grzebieniak E: Effect of hemodialysis on lipid peroxidation and antioxidant system in patients with chronic renal failure. Metabolism 1992, 41:1229-1232.
11. Epperlein MM, Nourooz-Zadeh J, Jayasena SD, Hothersall JS, Noronha-Dutra A, Neild GH: Nature and biological significance of free radicals generated during bicarbonate hemodialysis. J Am Soc Nephrol 1998, 9:457-463.
12. Fabrizi F, Lunghi G, Raffaele L, Guarnori I, Bacchini G, Corti M, Pagano A, Erba G, Locatelli F: Serologic survey for control of hepatitis C in haemodialysis patients: third-generation assays and analysis of costs. Nephrol Dial Transplant 1997, 12:298-303.
13. Fabrizi F, Bunnapradist S, Lunghi G, Aucella F, Martin P: Epidemiology and clinical significance of hepatotropic infections in dialysis patients. Minevra Urol Nephrol 2004, 56:249-257.
14. Farinati F, Cardin R, De Maria N, Della Libera G, Marafin C, Lecis E, Burra P, Floreani A, Cecchetto A, Naccarato R: Iron storage, lipid peroxidation and glutathione turnover in chronic anti-HCV positive hepatitis. J Hepatol 1995, 22:449-456.
15. De Maria N, Colantoni A, Fagiuoli S, Liu GJ, Rogers BK, Farinati F, Van Thiel DH, Floyd RA: Association between reactive oxygen species and disease activity in chronic hepatitis C. Free Radic Biol Med 1996, 21:291-5.
16. Koken T, Serteser M, Kahraman A, Gokce C: Oxidative stress markers in hepatitis C infected hemodialysis patients. J Nephrol 2002, 15:302-307.
17. Nascimento MM, Suliman ME, Bruchfeld A, Hayashi SY, Manfro RC, Qureshi AR, Pecoits-Filho R, Pachaly MA, Renner L, Stenvinkel P, Riella MC, Lindholm B: The influence of hepatitis C and iron replacement therapy on plasma pentosidine levels in haemodialysis patients. Nephrol Dial Transplant 2004, 19:3112-3116.
18. Kato A, Odamaki M, Nakamura H, Yodoi J, Hishida A: Elevation of blood thloredoxin in hemodialysis patients with hepatitis C virus infection. Kidney Int 2003, 63:2262-2268.
19. Erel O: A novel automated method to measure total antioxidant response against potent free radical reactions. Clin Biochem 2004, 37:112-119.
20. Harma M, Harma M, Erel O: Increased oxidative stress in patients with hydatidiform mole. Swiss Med Wkly 2003, 133:563-566.
21. Erel O: A new automated colorimetric method for measuring total oxidant status. Clin Biochem 2005, 38:1103-1111.
22. Cao G, Prior RL: Comparison of different analytical methods for assessing total antioxidant capacity of human serum. Clin Chem 1998, 44:1309-1315.
23. Miyazawa T: Determination of phospholipid hydroperoxides in human blood plasma by a chemiluminescence-HPLC assay. Free Radic Biol Med 1989, 7:209-217.
24. Descamps-Latscha B, Goldfarb B, Nguyen AT, Landais P, London G, Haeffner-Cavaillon N, Jacquot C, Herbelin A, Kazatchkine M: Establishing the relationship between complement activation and stimulation of phagocyte oxidative metabolism in hemodialyzed patients: a randomized prospective study. Nephron 1991, 59:279-285.
25. Peuchant E, Carbonneau MA, Dubourg L, Thomas MJ, Perromat A, Vallot C, Clerc M: Lipoperoxidation in plasma and red blood cells of patients undergoing haemodialysis: vitamin A, E and iron status. Free Radic Biol Med 1994, 16:339-3.
26. Miyata T, Wada Y, Cai Z, Iida Y, Horie K, Yasuda Y, Maeda K, Kurokawa K, van Ypersele de Strihou C: Implication of an increased oxidative stress in the formation of advanced glycation end products in patients with end-stage renal failure. Kidney Int 1997, 51:1170-1181.
27. Jain SK, Pemberton PW, Smith A, McMahon RF, Burrows PC, Aboutwerat A, Warnes TW: Oxidative stress in chronic hepatitis C: not just a feature of late stage disease. J Hepatol 2002, 36:805-811.
28. Wayner DD, Burton GW, Ingold KU, Barclay LR, Locke SJ: The relative contributions of vitamin E, urate, ascorbate and proteins to the total peroxyl radical-trapping antioxidant activity of human blood plasma. Biochim Biophys Acta 1987, 924:408-419.
29. Fabrizi F, Martin P, Dixit V, Brezina M, Cole MJ, Gerosa S, Vinson S, Mousa M, Gitnick G: Quantitative assessment of HCV load in chronic hemodialysis patients: a cross-sectional survey. Nephron 1998, 80:428-433.
30. Stehman-Breen CO, Emerson S, Gretch D, Johnson RJ: Risk of death among chronic dialysis patients infected with hepatitis C virus. Am J Kidney Dis 1998, 32:629-634.
31. Nakayama E, Akiba T, Marumo F, Sato C: Prognosis of anti-hepatitis C virus antibody-positive patients on regular hemodialysis therapy. J Am Soc Nephrol 2000, 11:1896-1902.
32. Zevin D, Malachi T, Gafter U, Friedman J, Levi J: Impaired DNA repair in patients with end-stage renal disease and its improvement with hemodialysis. Miner Electrolyte Metab 1991, 17:303-306.
33. Nakayama E, Akiba T, Marumo F, Sato C: Prognosis of anti-hepatitis C virus antibody-positive patients on regular hemodialysis therapy. J Am Soc Nephrol 2000, 11:1896-1902.
34. Tsukuma H, Hiyama T, Tanaka S, Nakao M, Yabuuchi T, Kitamura T, Nakanishi K, Fujimoto I, Inoue A, Yamazaki H, Kawashima T: Risk factors for hepatocellular carcinoma among patients with chronic liver disease. N Engl J Med 1993, 328:1797-1801.
35. Tokita H, Fukui H, Tanaka A, Kamitsukasa H, Yagura M, Harada H, Okamoto H: Risk factors for the development of hepatocellular carcinoma among patients with chronic hepatitis C who achieved a sustained virological response to interferon therapy. J Gastroenterol Hepatol 2005, 20:752-758.
36. Leone N, Rizzetto M: Natural history of hepatitis C virus infection: from chronic hepatitis to cirrhosis, to hepatocellular carcinoma. Minerva Gastroenterol Dietol 2005, 51:31-46.
37. Fabrizi F, Martin P, Dixit V, Brezina M, Cole MJ, Vinson S, Mousa M, Gitnick G: Biological dynamics of viral load in hemodialysis patients with hepatitis C virus. Am J Kidney Dis 2000, 35:122-129.
38. Martin J, de Sequera P, Quiroga JA, Rico M, Fernandez M, Arocena C, Caramelo C, Carreno V: Role of haemodialysis and hepatitis c virus infection in spontaneous and induced cytokine production of patients with chronic renal disease. Cytokine 2000, 12:1248-1252.